Financial Performance Summary

Jaykay Enterprises Ltd. announced its consolidated financial results for quarter ended June 30, 2026 (Q1 FY2026-27). The company is a diversified conglomerate with interests spanning Defence & Aerospace, Digital Manufacturing & Advanced Systems and Digital Services.

Consolidated Performance (Amount in Lakhs):

| Metric | Q1 FY2026-27 | Q1 FY2025-26 | Q4 FY2025-26 |

| Sales | 7,463 | 5,545 | 6,137 |

| Operating EBDITA | 1,062 | 688 | -611 |

Growth Rates:

  • Year-over-Year (YoY) Growth: Revenue increased by 35%, Operating EBITDA increased by 54%
  • Quarter-over-Quarter (QoQ) Growth: Revenue increased by 22%, Operating EBITDA showed turnaround from negative to positive

Segment-wise Performance (Amount in Lakhs)

Defence & Aerospace:

  • Q1 FY2026-27: Sales ₹579, Operating EBDITA ₹73
  • Q1 FY2025-26: Sales ₹732, Operating EBDITA -₹119
  • Q4 FY2025-26: Sales ₹1,240, Operating EBDITA ₹77

Digital Manufacturing:

  • Q1 FY2026-27: Sales ₹903, Operating EBDITA ₹59
  • Q1 FY2025-26: Sales ₹49, Operating EBDITA -₹10
  • Q4 FY2025-26: Sales -₹564, Operating EBDITA -₹1,355

Digital Services:

  • Q1 FY2026-27: Sales ₹5,981, Operating EBDITA ₹930
  • Q1 FY2025-26: Sales ₹4,764, Operating EBDITA ₹817
  • Q4 FY2025-26: Sales ₹5,461, Operating EBDITA ₹667

Business Highlights for Q1 FY2026-27

Defence & Aerospace:

  • Allen Reinforced Plastics Ltd. facilities at Bolaram, Hyderabad received AS9001:D certification
  • NABL accreditation received for its labs
  • Production at newly acquired Pune Plant is being ramped up with increasing traction in business of warheads and shells
  • Devanahalli Project remains on track and likely to be commissioned by Q4 FY2026-27

Digital Manufacturing:

  • Medical Implants:
  • All important certifications in place for Medical Implants
  • CDSO approvals in process
  • Intensive efforts on to build Distribution Channels for Medical Implants
  • Initial Market Response has been positive
  • Defence: New Additive Manufacturing based Products being developed for existing customers in Defence & Aerospace, likely to be a high growth area
  • Discussions at advanced stage with Global Suppliers for import of Medical grade Titanium for Implants and 3D Printing Machines

Management Commentary

Mr. Abhishek Singhania, Chairman and Managing Director, commented:

"Jaykay's Q1, FY2026-27 results continues the business momentum in Defence & Aerospace especially with Devanahalli Project on track. Medical Implants business has received exciting initial response from customers and scale-up is being pursued aggressively. The outlook for the remaining year appears robust and should continue the momentum in revenues & profitability."